Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Heinz Weidenthaler
Observed names:
H Weidenthaler,
H. Weidenthaler
Institution:
Bavarian Nordic (Germany)
Observed institutions:
Medigene (Germany),
Institut Jules Bordet,
Bavarian Nordic (Germany),
Centre Oscar Lambret,
Centre Antoine Lacassagne,
Dnipro State Medical University
show all 6
ORCID:
0000-0002-6866-4028
Observed ORCID:
0000-0002-6866-4028
OpenAlex ID:
A5013227120
The changing epidemiology of human monkeypox—A potential threat? A systematic review
2022
·
Eveline M. Bunge
, Bernard Hoet
, et al.
·
PLoS neglected tropical diseases
·
2,171
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
2019
·
Phillip R. Pittman
, Matthew Hahn
, et al.
·
New England Journal of Medicine
·
256
PDF
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS
2020
·
Edgar Turner Overton
, Steven J. Lawrence
, et al.
·
Vaccine
·
69
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
2020
·
Ariane Volkmann
, Anna-Lise Williamson
, et al.
·
Vaccine
·
65
PDF
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial
2018
·
Edgar Turner Overton
, Steven J. Lawrence
, et al.
·
PLoS ONE
·
65
PDF
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine
2020
·
Elke Jordan
, Steven J Lawrence
, et al.
·
The Journal of Infectious Diseases
·
61
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
2020
·
Nathaly Samy
, Daniela Reichhardt
, et al.
·
Vaccine
·
59
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines
2022
·
Heiko Ilchmann
, Nathaly Samy
, et al.
·
The Journal of Infectious Diseases
·
55
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
2023
·
Elke Jordan
, Golam Kabir
, et al.
·
The Journal of Infectious Diseases
·
44
PDF
A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adults
2022
·
Edgar Turner Overton
, Darja Schmidt
, et al.
·
Vaccine
·
21
PDF
Real-world safety data for MVA-BN: Increased frequency of syncope following intradermal administration for immunization against mpox disease
2024
·
Heinz Weidenthaler
, Sanja Vidojkovic
, et al.
·
Vaccine
·
13
MVA-BN as monkeypox vaccine for healthy and immunocompromised
2020
·
E.T. Overton
, S. Lawrence
, et al.
·
International Journal of Infectious Diseases
·
13
Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial
2024
·
Carlos Fierro
, Heinz Weidenthaler
, et al.
·
Vaccine
·
12
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
2024
·
Richard N. Greenberg
, Darja Schmidt
, et al.
·
Human Vaccines & Immunotherapeutics
·
11
PDF
P3-17-06: Final Results of a Controlled, Randomized 3-Arm Phase II Trial of EndoTAG”-1, a Cationic Liposomal Formulation of Paclitaxel Targeting Tumor Endothelial Cells, in Advanced Triple-Negative Breast Cancer (TNBC).
2011
·
A Awada
, IN Bondarenko
, et al.
·
Cancer Research
·
2
LB1579. A single and a two-dose regimen of MVA-BN elicit similar memory responses to a boost vaccination two years after the initial regimen, indicating potential flexibility for a delayed second dose of MVA-BN in the ongoing monkeypox emergency
2022
·
Heinz Weidenthaler
, Florian Lienert
, et al.
·
Open Forum Infectious Diseases
·
1
PDF
Smallpox and Other Orthopoxvirus Diseases
2022
·
Heinz Weidenthaler
·
1
A Randomized Phase 3 Trial to Assess the Immunogenicity and Safety of 3 Consecutively Produced Lots of Freeze-Dried MVA‑BN® Vaccine in Healthy Adults
2022
·
Edgar Turner Overton
, Darja Schmidt
, et al.
·
SSRN Electronic Journal
·
1
A Modified Vaccine against Smallpox. Reply.
2020
·
Phillip R Pittman
, Heinz Weidenthaler
, et al.
·
PubMed
·
1
LB747. Immune Responses of the Recombinant MVA-BN-RSV Vaccine against Respiratory Syncytial Virus Infection in an RSV Human Challenge Trial (HCT) in Healthy Adult Participants
2022
·
Darja Schmidt
, Günter Silbernagl
, et al.
·
Open Forum Infectious Diseases
Variole du singe
2022
·
Eveline M. Bunge
, Bernard Hoet
, et al.
·
Mains Libres
LB11. A Single Dose of the MVA-BN Smallpox Vaccine Induces an Early Protective Antibody Response Similar to a Traditional Replicating Vaccine and Is Suitable for Emergency Scenarios
2019
·
Jane Maclennan
, Heinz Weidenthaler
, et al.
·
Open Forum Infectious Diseases
Untersuchungen zum optimalen Zeitpunkt künftiger Immuntherapien mit monoklonalen Antikörpern bei Patienten mit Pankreaskarzinomen und einer Radiochemotherapie mit 5-Fluoruracil
2003
·
Heinz Weidenthaler
Show more works
View as search
Works count:
23
Citation count:
2,921
H-index:
12
I10-index:
14
Year
Topic
Type